Mangangot, Mindao T.
HRN: 22-11-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
CEFTRIAXONE 1G (VIAL)
11/02/2022
11/08/2022
IV
1gm
Q12
Open Fracture Distal 3rd Ulna
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes